Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Damask

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Investigative Ophthalmology & Visual Science|July 9, 2024
ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2Robyn H Guymer, Rufino Silva, Mercedeh Ghadessi, et al.
BMC Medical Genetics|July 2, 2011
Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiersMousheng Xu, Kelan G Tantisira, Ann Wu, et al.
Circulation. Genomic and Precision Medicine|May 11, 2022
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES TrialWilliam A Murphy, Nan Lin, Amy Damask, et al.
Human Genetics|June 8, 2012
Genome-wide association analysis of circulating vitamin D levels in children with asthmaJessica Lasky-Su, Nancy Lange, John M Brehm, et al.
Human Molecular Genetics|April 29, 2014
Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysisWeiliang Qiu, Angela J Rogers, Amy Damask, et al.
The Pharmacogenomics Journal|February 12, 2022
UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumabNan Lin, Amy Damask, Anita Boyapati, et al.
American Journal of Respiratory and Critical Care Medicine|April 28, 2012
Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locusKelan G Tantisira, Amy Damask, Stanley J Szefler, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2015
Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3Elliot Israel, Jessica Lasky-Su, Amy Markezich, et al.
Journal of the American Heart Association|August 23, 2025
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES TrialGregory P Geba, Kusha A Mohammadi, Amy Damask, et al.
Circulation|November 12, 2019
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES TrialAmy Damask, P Gabriel Steg, Gregory G Schwartz, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Investigative Ophthalmology & Visual Science|July 9, 2024
ANO2 Genetic Variants and Anti-VEGF Treatment Response in Neovascular AMD: A Pharmacogenetic Substudy of VIEW 1 and VIEW 2Robyn H Guymer, Rufino Silva, Mercedeh Ghadessi, et al.
BMC Medical Genetics|July 2, 2011
Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiersMousheng Xu, Kelan G Tantisira, Ann Wu, et al.
Circulation. Genomic and Precision Medicine|May 11, 2022
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES TrialWilliam A Murphy, Nan Lin, Amy Damask, et al.
Human Genetics|June 8, 2012
Genome-wide association analysis of circulating vitamin D levels in children with asthmaJessica Lasky-Su, Nancy Lange, John M Brehm, et al.
Human Molecular Genetics|April 29, 2014
Pharmacogenomics: novel loci identification via integrating gene differential analysis and eQTL analysisWeiliang Qiu, Angela J Rogers, Amy Damask, et al.
The Pharmacogenomics Journal|February 12, 2022
UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumabNan Lin, Amy Damask, Anita Boyapati, et al.
American Journal of Respiratory and Critical Care Medicine|April 28, 2012
Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locusKelan G Tantisira, Amy Damask, Stanley J Szefler, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2015
Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3Elliot Israel, Jessica Lasky-Su, Amy Markezich, et al.
Journal of the American Heart Association|August 23, 2025
Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES TrialGregory P Geba, Kusha A Mohammadi, Amy Damask, et al.
Circulation|November 12, 2019
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES TrialAmy Damask, P Gabriel Steg, Gregory G Schwartz, et al.
Pageof 2